Stroke-related pulmonary complications and abnormal respiratory patterns
- Julio A Chalela, MD
Julio A Chalela, MD
- Associate Professor of Neurology and Neurosurgery
- Medical University of South Carolina
Medical complications of acute ischemic stroke are common and often lead to poor clinical outcomes. The frequency of these complications must be recognized so that preventive strategies and appropriate treatment are employed.
The major pulmonary complications of acute stroke will be reviewed here. Other medical complications of acute stroke are discussed separately. (See "Medical complications of stroke" and "Cardiac complications of stroke".)
Pneumonia is one of the most common respiratory complications of acute stroke, occurring in about 5 to 9 percent of patients [1-3]. The incidence of stroke-related pneumonia appears to be higher in patients with acute ischemic stroke admitted to a neurologic intensive care unit and in those who require nasogastric tube feeding (21 and 44 percent, respectively) [4,5].
Patients with stroke-related pneumonia have a higher mortality and a poorer long-term outcome when compared with patients without pneumonia [2,3]. Pneumonia is the most common cause of fever within the first 48 hours of acute stroke, and it is the most common medical complication two to four weeks after a supratentorial ischemic infarction [1,6,7]. In addition, retrospective data suggest that pneumonia and respiratory illness are the most frequent diagnoses leading to hospital readmission in stroke survivors in the first five years after ischemic stroke .
In a prospective study of 412 patients with acute stroke, independent risk factors for in-hospital pneumonia were age >65 years, dysarthria or no speech due to aphasia, severe poststroke disability, cognitive impairment, and an abnormal water swallow test . In an earlier prospective study of 124 patients with acute stroke treated in the intensive care unit, risk factors were mechanical ventilation, abnormal chest radiograph on admission, and dysphagia . In patients requiring nasogastric feeding, independent risk factors for pneumonia were facial palsy and deceased level of consciousness .
- Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998; 29:447.
- Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011; 77:1338.
- Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke 2011; 42:3214.
- Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34:975.
- Dziewas R, Ritter M, Schilling M, et al. Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004; 75:852.
- Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke 1984; 15:492.
- Grau AJ, Buggle F, Schnitzler P, et al. Fever and infection early after ischemic stroke. J Neurol Sci 1999; 171:115.
- Bravata DM, Ho SY, Meehan TP, et al. Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare population. Stroke 2007; 38:1899.
- Sellars C, Bowie L, Bagg J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007; 38:2284.
- Herzig SJ, Doughty C, Lahoti S, et al. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia. Ann Neurol 2014; 76:712.
- Westendorp WF, Vermeij JD, Zock E, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet 2015; 385:1519.
- Kalra L, Irshad S, Hodsoll J, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015; 386:1835.
- Sekizawa K, Matsui T, Nakagawa T, et al. ACE inhibitors and pneumonia. Lancet 1998; 352:1069.
- Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 2005; 64:573.
- Ohkubo T, Chapman N, Neal B, et al. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004; 169:1041.
- van de Garde EM, Souverein PC, van den Bosch JM, et al. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006; 27:1217.
- Wijdicks EF, Scott JP. Causes and outcome of mechanical ventilation in patients with hemispheric ischemic stroke. Mayo Clin Proc 1997; 72:210.
- Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 1998; 51:447.
- Sulter G, Elting JW, Stewart R, et al. Continuous pulse oximetry in acute hemiparetic stroke. J Neurol Sci 2000; 179:65.
- Rowat AM, Wardlaw JM, Dennis MS, Warlow CP. Does feeding alter arterial oxygen saturation in patients with acute stroke? Stroke 2000; 31:2134.
- North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch Neurol 1974; 31:338.
- Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997; 28:1765.
- Lee MC, Klassen AC, Resch JA. Respiratory pattern disturbances in ischemic cerebral vascular disease. Stroke 1974; 5:612.
- Frank JI. Abnormal breathing patterns. In: Neurocritical Care, Hanley DF, Einhaupl KM, Bleck TP, Diringer MN (Eds), Springer-Verlag, Heidelberg 1994. p.366.
- Bogousslavsky J, Khurana R, Deruaz JP, et al. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol 1990; 28:668.